Retina: a unique subspecialty in the biosimilar landscape
Sign Up to like & getrecommendations! Published in 2022 at "Eye"
DOI: 10.1038/s41433-022-01984-w
Abstract: Retina as a subspecialty has transformed since the introduction of anti-vascular endothelial growth factor (anti-VEGF) therapeutics more than a decade ago. Approved intravitreal anti-VEGF agents such as ranibizumab (2006) and aflibercept (2011) have made a… read more here.
Keywords: ranibizumab; landscape; retina unique; anti vegf ... See more keywords